QTRX
Price
$11.76
Change
+$0.70 (+6.33%)
Updated
Oct 11 closing price
25 days until earnings call
SIBN
Price
$13.13
Change
+$0.06 (+0.46%)
Updated
Oct 11 closing price
23 days until earnings call
Ad is loading...

QTRX vs SIBN

Header iconQTRX vs SIBN Comparison
Open Charts QTRX vs SIBNBanner chart's image
Quanterix
Price$11.76
Change+$0.70 (+6.33%)
Volume$417.56K
CapitalizationN/A
SI-BONE
Price$13.13
Change+$0.06 (+0.46%)
Volume$236.12K
CapitalizationN/A
View a ticker or compare two or three
QTRX vs SIBN Comparison Chart
Loading...
QTRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SIBN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
QTRX vs. SIBN commentary
Oct 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QTRX is a Sell and SIBN is a StrongBuy.

COMPARISON
Comparison
Oct 13, 2024
Stock price -- (QTRX: $11.76 vs. SIBN: $13.13)
Brand notoriety: QTRX and SIBN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: QTRX: 97% vs. SIBN: 76%
Market capitalization -- QTRX: $907.82M vs. SIBN: $672.23M
QTRX [@Medical Specialties] is valued at $907.82M. SIBN’s [@Medical Specialties] market capitalization is $672.23M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QTRX’s FA Score shows that 0 FA rating(s) are green whileSIBN’s FA Score has 0 green FA rating(s).

  • QTRX’s FA Score: 0 green, 5 red.
  • SIBN’s FA Score: 0 green, 5 red.
According to our system of comparison, both QTRX and SIBN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QTRX’s TA Score shows that 4 TA indicator(s) are bullish while SIBN’s TA Score has 4 bullish TA indicator(s).

  • QTRX’s TA Score: 4 bullish, 6 bearish.
  • SIBN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both QTRX and SIBN are a bad buy in the short-term.

Price Growth

QTRX (@Medical Specialties) experienced а -1.18% price change this week, while SIBN (@Medical Specialties) price change was -10.56% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.01%. For the same industry, the average monthly price growth was +3.93%, and the average quarterly price growth was -2.96%.

Reported Earning Dates

QTRX is expected to report earnings on Mar 04, 2025.

SIBN is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Medical Specialties (-2.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QTRX($908M) has a higher market cap than SIBN($672M). SIBN YTD gains are higher at: -37.446 vs. QTRX (-56.986). SIBN has higher annual earnings (EBITDA): -34.45M vs. QTRX (-39.79M). QTRX has more cash in the bank: 321M vs. SIBN (166M). SIBN has less debt than QTRX: SIBN (39M) vs QTRX (41.5M). SIBN has higher revenues than QTRX: SIBN (139M) vs QTRX (121M).
QTRXSIBNQTRX / SIBN
Capitalization908M672M135%
EBITDA-39.79M-34.45M115%
Gain YTD-56.986-37.446152%
P/E RatioN/AN/A-
Revenue121M139M87%
Total Cash321M166M193%
Total Debt41.5M39M106%
FUNDAMENTALS RATINGS
QTRX vs SIBN: Fundamental Ratings
QTRX
SIBN
OUTLOOK RATING
1..100
6764
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9395
PRICE GROWTH RATING
1..100
8683
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QTRX's Valuation (35) in the Pharmaceuticals Major industry is in the same range as SIBN (45) in the Medical Specialties industry. This means that QTRX’s stock grew similarly to SIBN’s over the last 12 months.

QTRX's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as SIBN (100) in the Medical Specialties industry. This means that QTRX’s stock grew similarly to SIBN’s over the last 12 months.

QTRX's SMR Rating (93) in the Pharmaceuticals Major industry is in the same range as SIBN (95) in the Medical Specialties industry. This means that QTRX’s stock grew similarly to SIBN’s over the last 12 months.

SIBN's Price Growth Rating (83) in the Medical Specialties industry is in the same range as QTRX (86) in the Pharmaceuticals Major industry. This means that SIBN’s stock grew similarly to QTRX’s over the last 12 months.

SIBN's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as QTRX (100) in the Pharmaceuticals Major industry. This means that SIBN’s stock grew similarly to QTRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
QTRXSIBN
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 5 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 24 days ago
82%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 11 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
74%
View a ticker or compare two or three
Ad is loading...
QTRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SIBN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X62445.0900002170.586000
+3.60%
Bitcoin cryptocurrency
SPY579.583.45
+0.60%
SPDR® S&P 500® ETF Trust
GME20.83-0.08
-0.38%
GameStop Corp
AAPL227.55-1.49
-0.65%
Apple
TSLA217.80-20.97
-8.78%
Tesla

QTRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTRX has been loosely correlated with LUNG. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if QTRX jumps, then LUNG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTRX
1D Price
Change %
QTRX100%
+6.33%
LUNG - QTRX
52%
Loosely correlated
+3.41%
SIBN - QTRX
44%
Loosely correlated
+0.46%
BLFS - QTRX
44%
Loosely correlated
+1.80%
MASS - QTRX
43%
Loosely correlated
+4.52%
KIDS - QTRX
43%
Loosely correlated
+1.61%
More

SIBN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SIBN has been loosely correlated with KIDS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SIBN jumps, then KIDS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIBN
1D Price
Change %
SIBN100%
+0.46%
KIDS - SIBN
51%
Loosely correlated
+1.61%
FNA - SIBN
46%
Loosely correlated
+7.32%
QTRX - SIBN
44%
Loosely correlated
+6.33%
LUNG - SIBN
42%
Loosely correlated
+3.41%
AORT - SIBN
42%
Loosely correlated
+1.89%
More